Trials / Sponsors / Gladwin, Mark, MD

Gladwin, Mark, MD

Individual · 13 registered clinical trials.

Status	Trial	Phase	Started
Withdrawn	Chlorhexidine Mouthwash and Oral Nitrate in Adults With Pulmonary Hypertension Pulmonary Hypertension, Heart Failure With Normal Ejection Fraction, Pulmonary Heart Disease and Diseases of Pulmonary Circulation	Phase 1	2022-12-01
Completed	Nitrites, Skeletal Muscle Mitochondrial Bioenergetics, and Physical Activity in Old Age Aging, Sedentary Lifestyle, Frailty	Phase 2	2021-04-23
Withdrawn	Oral Nitrite Trial for Hypertension and Metabolic Syndrome Metabolic Syndrome, Hypertension	Phase 2	2020-10-01
Terminated	Oral CXA-10 in Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension	Phase 2	2019-10-31
Terminated	Transfusion of Biotin-Labeled Red Blood Cells Healthy Volunteers	Phase 2	2019-09-16
Completed	A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fracti Pulmonary; Hypertension, Heart Failure, Preserved Ejection Fraction	Phase 1	2017-08-28
Completed	Oral Nitrite for Older Heart Failure With Preserved Ejection Fraction Heart Failure	Phase 2	2017-04-03
Completed	Oral Nitrite for Older Heart Failure Patients Heart Failure	Phase 2	2016-01-08
Completed	The Effects of NOx and Conjugated Linoleic Acid on Asthmatics Asthma	Phase 2	2015-09-01
Completed	Oral Nitrite in Adults With Metabolic Syndrome and Hypertension Metabolic Syndrome, Hypertension	Phase 2	2012-10-01
Completed	Oral Nitrite and Nitrate in Healthy Normal Volunteer Adults Focus of Study of Healthy Adults	Phase 1	2012-10-01
Terminated	Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation Cardiac Allograft Vasculopathy, Antibody Mediated Rejection	Phase 1	2012-09-01
Terminated	Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction Primary Graft Dysfunction	Phase 2	2011-10-01